Shoulder Innovations (NYSE:SI) Announces Earnings Results, Misses Expectations By $63.95 EPS

Key Points

• Shoulder Innovations reported a quarterly loss of ($64.47) earnings per share, reflecting challenges in its financial performance.
• The company's stock saw a 7.9% increase, with a current price of $16.03 and a market capitalization of approximately $244.14 million.
• Analysts are optimistic, with multiple firms issuing buy ratings and a consensus price target of $19.60 for the stock.

Shoulder Innovations (NYSE:SI - Get Free Report) issued its quarterly earnings results on Tuesday. The company reported ($64.47) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.52) by ($63.95), Zacks reports. The company had revenue of $11.01 million during the quarter, compared to analyst estimates of $11.00 million. Shoulder Innovations updated its FY 2025 guidance to EPS.

Shoulder Innovations Price Performance

NYSE SI traded up $0.72 on Friday, hitting $15.72. 143,494 shares of the company's stock were exchanged, compared to its average volume of 177,190. Shoulder Innovations has a 52 week low of $11.75 and a 52 week high of $17.94. The stock has a market capitalization of $239.42 million and a PE ratio of -0.52.

Wall Street Analyst Weigh In

Several equities research analysts recently issued reports on the company. Morgan Stanley assumed coverage on Shoulder Innovations in a research note on Monday, August 25th. They issued an "overweight" rating and a $18.00 price target for the company. Zacks Research upgraded Shoulder Innovations to a "hold" rating in a research note on Tuesday, August 26th. BTIG Research restated a "buy" rating and set a $23.00 target price on shares of Shoulder Innovations in a research note on Tuesday. Jefferies Financial Group assumed coverage on Shoulder Innovations in a research note on Monday, August 25th. They set a "buy" rating and a $19.00 target price for the company. Finally, Piper Sandler assumed coverage on Shoulder Innovations in a research note on Monday, August 25th. They set an "overweight" rating and a $18.00 target price for the company. Five research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $19.60.

Insider Buying and Selling

In other news, Director Michael A. Carusi purchased 266,666 shares of the company's stock in a transaction dated Friday, August 1st. The stock was bought at an average cost of $15.00 per share, for a total transaction of $3,999,990.00. Following the purchase, the director owned 1,885,136 shares of the company's stock, valued at approximately $28,277,040. The trade was a 16.48% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through the SEC website. Also, major shareholder Lsv Associates Ii, Llc purchased 266,666 shares of the company's stock in a transaction dated Friday, August 1st. The stock was purchased at an average price of $15.00 per share, with a total value of $3,999,990.00. Following the completion of the purchase, the insider directly owned 1,885,136 shares in the company, valued at $28,277,040. The trade was a 16.48% increase in their position. The disclosure for this purchase can be found here. Insiders purchased 778,382 shares of company stock worth $11,675,730 in the last ninety days. Insiders own 1.71% of the company's stock.

Shoulder Innovations Company Profile

We are a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. We currently offer advanced implant systems for shoulder arthroplasty. These systems are a core element of our ecosystem, which we designed to improve core components of shoulder surgical care – preoperative planning, implant design and procedural efficiency – to benefit each stakeholder in the care chain.